We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
    • Webinar Recordings
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

Pfizer Seeks Full FDA Approval for Oral COVID-19 Therapy Paxlovid

July 1, 2022
Pfizer is jockeying for full FDA approval of its oral antiviral COVID-19 treatment, Paxlovid, which would allow the company to sell the drug commercially. Read More

Eli Lilly to Supply 150,000 More Doses of Bebtelovimab to U.S. Government

July 1, 2022
The company said the delivery of the additional doses will begin immediately and will be completed no later than August 5. Read More

U.S. Government Inks $3.2 Billion Contract With Pfizer-BioNTech for Vaccine Booster Campaign

July 1, 2022
The companies plan to deliver doses as soon as this summer and will continue into the fourth quarter of this year. Read More

LumiraDx Gets CE Mark for Two Multiplex Tests That Can Identify COVID-19

July 1, 2022
Results from the two assays are comparable to high-sensitivity RT-PCR tests, the company said. Read More

AeroClean Granted FDA Clearance for Its Pūrgo Medical-Grade Air Hygiene Tech

June 30, 2022
The device delivers hospital-grade HEPA filtration and germicidal ultraviolet irradiation. Read More

FDA Expert Panel Recommends Omicron-Updated COVID-19 Booster Shots

June 29, 2022
The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19 to 2 yesterday in favor of including a SARS-CoV-2 Omicron component in COVID-19 booster shots. Read More

DxLab Gets FDA’s Emergency Use Authorization for Its COVID-19 Test

June 29, 2022
The test can be used for qualitative detection of nucleic acid from the SARS-CoV-2 coronavirus from nasal swab samples from individuals suspected by their healthcare provider of being infected with COVID-19. Read More

Sanofi and GSK Present Promising Data for Bivalent COVID-19 Vaccine

June 27, 2022
Sanofi said the immunogenicity data support the use of the bivalent vaccine against variants including Omicron. Read More

LG Chem’s COVID-19 Antibody Test Gains Emergency Authorization

June 24, 2022
Samples should only be taken for this test from individuals who are 15 days or more post symptom onset, the FDA said. Read More

Moderna to Create mRNA Manufacturing Facility in the UK

June 23, 2022
Moderna is also collaborating with the UK’s National Institute for Health Research on a phase 3 study investigating the company’s bivalent Omicron-containing booster candidate. Read More

Euroimmun Gets CE Marks for Two COVID-19 Assays

June 23, 2022
Both test systems are now available to laboratories in countries that accept the CE mark, the company said. Read More

Sinopharm COVID-19 Shots Show Little Efficacy Against Omicron Subvariants

June 22, 2022
The vaccine produced a detectable neutralizing response against the spike protein mutation D614G in 84 percent of individuals. Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 174 175 Next

Upcoming Events

  • 07Dec

    Proactive Supplier Management Using Quality Agreements

  • 13Dec

    FDA Inspection Overhaul: How Things Have Changed in 2023

  • 14Apr

    MAGI 2024: The Clinical Research Conference

Featured Products

  • FDA, FTC and DOJ Enforcement of Medical Device Regulations

    FDA, FTC and DOJ Enforcement of Medical Device Regulations

  • Using Real-World Evidence in Drug and Device Submissions

    Using Real-World Evidence in Drug and Device Submissions

Featured Stories

  • FDA Laboratory-Developed Tests Proposal Comments Pour In by Thousands

  • Healthcare Titans Expand Their Portfolios in Acquisition Deals

  • Ups and Downs of Gene Therapy Weighed by FDA’s Marks

  • Device Manufacturers Pressed by Europe’s MDCG to Get Certified ASAP

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing